company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Agios Pharmaceuticals Inc,AGIO,,0001439222,2012.0,Q3,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4645000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4645000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,319000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,65000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,187000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-7325000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11399000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11399000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1141000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-20461000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,19880000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2012.0,Q3,2012-07-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1722000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1722000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-54000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,88000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,34000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,34000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2012.0,Q3,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-13087000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2012.0,Q3,2012-07-01,2012-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,49000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5313000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5313000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,323000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,55000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,393000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-7087000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11629000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11629000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-26000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-17414000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,37277000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2012.0,Q4,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,19837000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,19837000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,54000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,54000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,54000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2012.0,Q4,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,8262000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:02:50+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7228000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:02:50+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7228000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:02:50+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,349000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:02:50+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-5000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:02:50+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,409000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:02:50+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5506000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:02:50+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11981000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:02:50+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11981000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:02:50+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-275000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:02:50+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-15915000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:02:50+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,20226000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:02:50+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,4036000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:02:50+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,4036000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:02:50+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,25000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:02:50+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,25000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:02:50+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,25000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:02:50+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-7920000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8620000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8620000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,374000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-4000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,344000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-7916000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-15822000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-15822000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-701000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-7280000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,17860000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,9879000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,9879000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,47000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,47000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,47000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5896000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11177000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11177000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,377000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,90000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1112000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5382000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-14980000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-14980000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-99000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-96303000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,15680000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-80722000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-80722000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,124204000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,28000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,124232000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,124232000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,28530000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12382000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12382000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,340000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,203000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1165000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2943000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13617000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13617000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-219000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-26551000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,6360000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-20410000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-20410000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-2387000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1913000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,50000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-424000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-424000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-34451000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:16:19+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12248000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:16:19+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12248000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:16:19+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,332000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:16:19+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,168000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:16:19+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1505000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:16:19+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-16797000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:16:19+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-27040000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:16:19+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-27040000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:16:19+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-13000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:16:19+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-34812000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:16:19+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,22560000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:16:19+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-12265000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:16:19+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-12265000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:16:19+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,582000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:16:19+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,582000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:16:19+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,582000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:16:19+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-38723000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:16:19+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,5958000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,0.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-1071000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-1071000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-86000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-91526000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,72941000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-18671000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-18671000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,94698000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,454000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,95152000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,95152000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,75410000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,0.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-23467000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-23467000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-628000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-89045000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,74004000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,571000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-15098000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-15098000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-13000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,380000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,367000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,367000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-38198000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-26664000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-26664000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,362000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,126000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4728000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,13673000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7775000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7775000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1489000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-621836000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,336023000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-287302000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-287302000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,239059000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,239059000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-56018000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2014.0,Q4,2014-10-01,2014-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,22000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 08:06:34+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4957000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 08:06:34+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4957000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 08:06:34+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,370000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 08:06:34+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,172000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 08:06:34+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5060000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 08:06:34+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-26230000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 08:06:34+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-25585000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 08:06:34+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-25585000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 08:06:34+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3797000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 08:06:34+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-35526000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 08:06:34+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,84311000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 08:06:34+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,44988000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 08:06:34+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,44988000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 08:06:34+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-207000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 08:06:34+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2029000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 08:06:34+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1822000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 08:06:34+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1822000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 08:06:34+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,21225000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-31897000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-31897000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,780000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,147000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8177000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,26773000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3980000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3980000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-10882000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-70679000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,113767000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,32206000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,32206000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1091000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1091000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1091000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,37277000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-40256000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-40256000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1047000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,112000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,9373000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4909000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-24815000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-24815000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3299000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-112452000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,145908000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,30157000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,30157000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2173000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2173000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2173000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,7515000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-40622000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-40622000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1145000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,108000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7653000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1187000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-30529000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-30529000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2186000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-134520000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,157664000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,20958000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,20958000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,6580000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-5293000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1287000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1287000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-8284000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 11:58:56+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23198000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 11:58:56+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23198000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 11:58:56+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1246000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 11:58:56+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,126000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 11:58:56+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,9107000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 11:58:56+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6290000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 11:58:56+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-19009000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 11:58:56+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-19009000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 11:58:56+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2533000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 11:58:56+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-211163000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 11:58:56+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,198868000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 11:58:56+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-14828000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 11:58:56+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-14828000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 11:58:56+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1108000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 11:58:56+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1108000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 11:58:56+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1108000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 11:58:56+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-32729000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-55953000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-55953000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1304000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,204000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,10996000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,201273000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,157824000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,157824000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2734000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-15126000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,53600000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,35740000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,35740000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1449000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1449000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1449000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,195013000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-62834000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-62834000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1436000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,204000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,12186000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-22000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-49030000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-49030000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3426000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-141298000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,81980000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-62744000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-62744000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,163476000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,163476000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,163228000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,51454000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-56486000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-56486000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1714000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,239000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,13136000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-9834000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-51231000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-51223000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1222000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-138480000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,62184000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-77518000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-77518000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3993000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-124748000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 12:10:14+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-66166000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 12:10:14+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-66166000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 12:10:14+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1591000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 12:10:14+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,163000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 12:10:14+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4395000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 12:10:14+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-14057000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 12:10:14+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-74074000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 12:10:14+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-74074000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 12:10:14+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-293000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 12:10:14+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-26740000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 12:10:14+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,136585000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 12:10:14+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,109552000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 12:10:14+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,109552000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 12:10:14+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-100000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 12:10:14+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,4146000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 12:10:14+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4046000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 12:10:14+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4046000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 12:10:14+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,39524000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-83082000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-83082000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1573000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-69000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,18566000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4023000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-58989000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-58989000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1035000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-441816000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,167126000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-275725000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-275725000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-4000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,272949000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,272945000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,273153000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-61561000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-77137000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-77137000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1614000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-69000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,12889000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-15012000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-77715000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-77715000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2019000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-135969000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,204405000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,66417000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,66417000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5322000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5976000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-88285000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-88285000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1654000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-36000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,13215000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1002000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-74454000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-74454000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1280000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-84177000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,127305000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,41848000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,41848000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2589000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-30017000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 08:57:30+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-90825000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 08:57:30+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-90825000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 08:57:30+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1725000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 08:57:30+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-406000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 08:57:30+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,13263000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 08:57:30+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-22757000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 08:57:30+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-99000000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 08:57:30+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-99000000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 08:57:30+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1432000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 08:57:30+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-330971000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 08:57:30+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,164871000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 08:57:30+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-167532000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 08:57:30+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-167532000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 08:57:30+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,528653000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 08:57:30+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,528653000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 08:57:30+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,528277000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 08:57:30+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,261745000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-68745000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-68745000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1739000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-885000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,25000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,471000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-67395000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-67395000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1361000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-261693000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,166795000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-96259000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-96259000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,9508000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-154146000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-94664000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-94664000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1797000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-1249000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,37203000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6926000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-63839000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-63839000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3140000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-162704000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,168615000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2771000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2771000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,7223000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,7223000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,7223000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-53845000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-91794000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-91794000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1911000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-1297000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,16114000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,879000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-74187000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-74187000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1053000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-177952000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,166200000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-12805000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-12805000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1016000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1016000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1016000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-85976000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 09:47:20+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-93078000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 09:47:20+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-93078000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 09:47:20+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2005000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 09:47:20+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,954000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 09:47:20+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,18036000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 09:47:20+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-31188000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 09:47:20+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-103271000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 09:47:20+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-103271000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 09:47:20+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2038000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 09:47:20+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-77421000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 09:47:20+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,210811000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 09:47:20+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,131352000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 09:47:20+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,131352000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 09:47:20+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,4860000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 09:47:20+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 09:47:20+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4860000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 09:47:20+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4860000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 09:47:20+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,32941000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-109871000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-109871000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2037000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1235000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,14468000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3980000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-88151000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-88151000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1271000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-66810000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,132561000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,64480000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,64480000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3808000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3808000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3808000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-19863000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-106173000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-106173000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2082000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1380000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,21234000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4112000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-85589000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-85589000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2038000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-50591000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,133010000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,80381000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,80381000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3337000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3337000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3337000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1871000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-102350000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-102350000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1963000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1768000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,14810000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-9802000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-93611000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-93611000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-6824000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-293744000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,115795000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q4,2019-10-01,2019-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-184773000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-184773000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,277719000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,113000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,277832000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,277606000.0
Agios Pharmaceuticals Inc,AGIO,,0001439222,2019.0,Q4,2019-10-01,2019-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-778000.0
